By tracking an older person’s movements at home, a new wearable device could help predict serious changes in health.
High-tech blood tests should replace ultrasound and other methods as the primary tools for screening for Down syndrome, argue researchers.
A single-molecule gene test requires much less DNA to identify cancer-causing mutations.
A molecular diagnosis gives doctors and patients better treatment options when suspicious lumps are found in the neck.
Now that genomes can be sequenced for $1,000, more patients can benefit, says Howard Jacob.
A new nerve interface gives a sense of touch to a prosthetic limb.
These VCs don’t wait for biotech startups to come to them. They create companies themselves.
After outflanking and outlasting competitors, it is on top of the genome-sequencing business—just as that market is about to soar in importance.
Researchers find a way to turn pain on, and off, with a beam of light.
Researchers are testing whether high-throughput DNA sequencing can help screen out abnormal embryos during in vitro fertilization.